Cooperative Groups Meet With NCI to Discuss Plan to use Rosenberg’s Regimen At Member Institutions
In Brief; Jerome Green To Head NIH Div. Of Research Grants; M.D. Anderson’s Even Hersh To Join Univ. of Arizona
Burton’s Clinic Reported Operating In Spite of Closure
MSKCC Asked To Repay $638,371 To NIH
Toxic Wastes And Cancer Linked; NCI Data Questioned In Bay Study
Abstracts Deadline For Cancer Congress Extended To Dec. 31
Final Issue of the Year
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
